RecruitingNCT06694012
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Sponsor
Osaka Metropolitan University
Enrollment
2,000 participants
Start Date
Nov 1, 2024
Study Type
OBSERVATIONAL
Conditions
Diabetes MellitusInsulin Sensitivity/ResistanceObesityMetabolic SyndromeHypertensionAtherosclerosisType 2 Diabetes Mellitus (T2DM)Type 2 DiabetesChronic Kidney Disease(CKD)HyperglycemiaHyperlipidemiaDyslipidemiaHyperuricemia or GoutHyperuricemia, GoutObesity/EpidemiologyObesity, AbdominalCentral ObesityVisceral FatHepatic Steatosis
Summary
The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and cardiovascular disease in a prospective cohort study of Japanese men and women. The investigators will also investigate novel risk factors for metabolic and cardiovascular disease using molecular weight-based metallomics analysis.
Eligibility
Min Age: 20 Years
Inclusion Criteria1
- \-
Exclusion Criteria1
- Women who may be pregnant
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06694012
Related Trials
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
NCT0729648446 locations
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
NCT0724708425 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418115 locations
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
NCT070107571 location